Expertise in
2
conditions

Michihiro Ueda

Sapporo, JP 
Expertise in
2
conditions
Sapporo, JP 

Overview

Michihiro Ueda practices practicing medicine in Sapporo, Japan.

Ueda is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Oral Squamous Cell Carcinoma, Tongue Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Osteonecrosis.

They are actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 1 clinical trial.

Locations

Sapporo, 0030804, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, 2-arm Phase III Study to Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of Disease-free Survival in Participants With Resected Squamous Cell Carcinoma of the Head and Neck, Who Are at High Risk for Relapse and Are Ineligible for High-dose Cisplatin (XRAY VISION)
A Randomized, Double-blind, Placebo-controlled, 2-arm Phase III Study to Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of Disease-free Survival in Participants With Resected Squamous Cell Carcinoma of the Head and Neck, Who Are at High Risk for Relapse and Are Ineligible for High-dose Cisplatin (XRAY VISION)
Enrollment Status: Terminated
Publish Date: February 19, 2026
Intervention Type: Drug, Radiation
Study Phase: Phase 3

26 Total Publications

Efficacy and risks of drug holiday in the management of medication-related osteonecrosis of the jaw in cancer patients: a single-center retrospective study.
Efficacy and risks of drug holiday in the management of medication-related osteonecrosis of the jaw in cancer patients: a single-center retrospective study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 14, 2025

Frequently Asked Questions about Michihiro Ueda

Is Michihiro Ueda a top-rated expert for Oral Squamous Cell Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Michihiro Ueda is classified as an Advanced expert for Oral Squamous Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michihiro Ueda participate in research or clinical trials?

Yes. Michihiro Ueda has published 26 articles and abstracts on conditions like Oral Squamous Cell Carcinoma. You can view a list of Michihiro Ueda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ueda's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile